FLT3 and acute myeloid leukemia: In AML, candidate antigens such as CD123 (11), folate-receptor β (12) or FLT-3 are expressed early in myeloid differentiation and CAR T-cell mediated targeting may result in significant and potentially permanent myeloablation (13).